Miller DM - Search Results

1

High MITF Expression Is Associated with Super-Enhancers and Suppressed by CDK7 Inhibition in Melanoma.

Eliades P, Abraham BJ, Ji Z, Miller DM, Christensen CL, Kwiatkowski N, Kumar R, Njauw CN, Taylor M, Miao B, Zhang T, Wong KK, Gray NS, Young RA, Tsao H. Eliades P, et al. Among authors: miller dm. J Invest Dermatol. 2018 Jul;138(7):1582-1590. doi: 10.1016/j.jid.2017.09.056. Epub 2018 Feb 8. J Invest Dermatol. 2018. PMID: 29408204 Free PMC article.

2

Commentary: Molecular testing in melanoma.

Miller DM, Flaherty KT, Tsao H. Miller DM, et al. J Am Acad Dermatol. 2014 May;70(5):863-70. doi: 10.1016/j.jaad.2014.01.866. Epub 2014 Feb 16. J Am Acad Dermatol. 2014. PMID: 24534656 No abstract available.

3

Current status and future directions of molecularly targeted therapies and immunotherapies for melanoma.

Miller DM, Flaherty KT, Tsao H. Miller DM, et al. Semin Cutan Med Surg. 2014 Jun;33(2):60-7. doi: 10.12788/j.sder.0081. Semin Cutan Med Surg. 2014. PMID: 25085663 Review.

4

A novel multi-CDK inhibitor P1446A-05 restricts melanoma growth and produces synergistic effects in combination with MAPK pathway inhibitors.

Eliades P, Miller DM, Miao B, Kumar R, Taylor M, Buch S, Srinivasa SP, Flaherty KT, Tsao H. Eliades P, et al. Among authors: miller dm. Cancer Biol Ther. 2016 Jul 2;17(7):778-84. doi: 10.1080/15384047.2016.1139267. Cancer Biol Ther. 2016. PMID: 26810603 Free PMC article.

5

Somatic driver mutations in melanoma.

Reddy BY, Miller DM, Tsao H. Reddy BY, et al. Among authors: miller dm. Cancer. 2017 Jun 1;123(S11):2104-2117. doi: 10.1002/cncr.30593. Cancer. 2017. PMID: 28543693 Free article. Review.

6

Clinical spectrum of cutaneous melanoma morphology.

Klebanov N, Gunasekera NS, Lin WM, Hawryluk EB, Miller DM, Reddy BY, Christman MP, Beaulieu D, Rajadurai S, Duncan LM, Sober AJ, Tsao H. Klebanov N, et al. Among authors: miller dm. J Am Acad Dermatol. 2019 Jan;80(1):178-188.e3. doi: 10.1016/j.jaad.2018.08.028. Epub 2018 Aug 28. J Am Acad Dermatol. 2019. PMID: 30165162 Free PMC article.

7

Cyclin-dependent kinases as therapeutic targets in melanoma.

Miller DM, Flaherty KT. Miller DM, et al. Pigment Cell Melanoma Res. 2014 May;27(3):351-65. doi: 10.1111/pcmr.12211. Epub 2014 Feb 10. Pigment Cell Melanoma Res. 2014. PMID: 24405945 Review.

8

Inhibition of Haspin Kinase Promotes Cell-Intrinsic and Extrinsic Antitumor Activity.

Melms JC, Vallabhaneni S, Mills CE, Yapp C, Chen JY, Morelli E, Waszyk P, Kumar S, Deming D, Moret N, Rodriguez S, Subramanian K, Rogava M, Cartwright ANR, Luoma A, Mei S, Brinker TJ, Miller DM, Spektor A, Schadendorf D, Riggi N, Wucherpfennig KW, Sorger PK, Izar B. Melms JC, et al. Among authors: miller dm. Cancer Res. 2020 Feb 15;80(4):798-810. doi: 10.1158/0008-5472.CAN-19-2330. Epub 2019 Dec 27. Cancer Res. 2020. PMID: 31882401 Free PMC article.

9

Evaluation of the fragility of pivotal trials used to support US Food and Drug Administration approval for plaque psoriasis.

Shalhout SZ, Bloom R, Drake L, Miller DM. Shalhout SZ, et al. Among authors: miller dm. J Am Acad Dermatol. 2021 Feb;84(2):354-360. doi: 10.1016/j.jaad.2020.04.057. Epub 2020 Apr 19. J Am Acad Dermatol. 2021. PMID: 32320767

10

Real-world assessment of response to anti-programmed cell death 1 therapy in advanced cutaneous squamous cell carcinoma.

Shalhout SZ, Park JC, Emerick KS, Sullivan RJ, Kaufman HL, Miller DM. Shalhout SZ, et al. Among authors: miller dm. J Am Acad Dermatol. 2021 Oct;85(4):1038-1040. doi: 10.1016/j.jaad.2021.01.048. Epub 2021 Jan 19. J Am Acad Dermatol. 2021. PMID: 33476726 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

733 results

Search Page

Filters